5th Annual Healthcare Conference
a a
aConf Logo


Essner Robert A. Essner
Former Chairman & CEO  Wyeth

Executive-in-Residence Columbia Business School
Ludwig Edward J. Ludwig ('75)
Chairman & CEO
BD (Becton Dickinson)



Moderator: Cliff Cramer
Director, Healthcare and Pharmaceutical Management Program 
Adjunct Professor, Columbia Business School

Mr. Cramer spent over 25 years as a senior professional in the financial services and healthcare/ pharmaceutical sectors.  He was Managing Director at Merrill Lynch and JP Morgan in their global healthcare investment banking groups, and Vice President, Corporate Planning & Development at Merck & Co., Inc., with worldwide responsibilities for strategic planning and business development.

Mr. Cramer’s previous experiences also include the co-founding of American Health Capital / VHA Enterprises, Inc., a healthcare/ financial services firm serving the capital needs of multi-hospital systems and other healthcare providers, and investment banking positions with Paine Webber, Inc. and L.F. Rothschild, Unterberg, Towbin, Inc.

Mr. Cramer is currently Director of the Healthcare and Pharmaceutical Management Program and Adjunct Professor at Columbia University, Graduate School of Business.  He teaches two courses in the spring semester: Strategy and Competition in Pharmaceuticals and Biotechnology, and Healthcare Investment and Dealmaking.


Moderator: Linda V. Green, PhD
Armand G. Erpf Professor, Columbia Business School

Linda V. Green is the Armand G. Erpf Professor at Columbia Business School. She earned her doctorate in Operations Research from Yale University. Her research, which has focused on the development and application of mathematical models of service systems, has resulted in dozens of publications in the major technical journals including Operations Research, Management Science, and The Journal of Applied Probability as well as prominent healthcare journals such as Health Services Research, Inquiry and Academic Emergency Medicine. Her early work led to the development of a model for the dispatching and allocation of emergency vehicles which became the foundation for a patrol car allocation model that is used by many major cities in the U.S. as well as several other countries. Her current research is on identifying operational policies to improve the delivery of healthcare. Specific projects focus on improving emergency responsiveness, developing strategies for the efficient and effective use of major diagnostic equipment such as MRIs, providing timely access to primary care, and the development of a new nurse staffing methodology. She is a co-founder and co-director of the Columbia Alliance for Healthcare Management, a unique partnership of the College of Physicians and Surgeons, the Mailman School of Public Health and the Business School of Columbia University dedicated to promoting interdisciplinary research and education in healthcare management. She has been a consultant for both private and public sector organizations and has served on several advisory boards. She has served in many administrative positions at both Columbia and in the major professional societies and is currently the Department Editor for Public Sector Applications for the journal Management Science. In recognition of her professional achievements, Professor Green was elected a Fellow of INFORMS, the premier international professional society for operations research and management science.


Moderator: Frank R. Lichtenberg, PhD
Courtney C. Brown Professor of Business
Columbia Universtiy Graduate School of Business

Frank R. Lichtenberg is Courtney C. Brown Professor of Business at the Columbia University Graduate School of Business, and a Research Associate of the National Bureau of Economic Research.  He received a BA with Honors in History from the University of Chicago and an MA and PhD in Economics from the University of Pennsylvania.  

Professor Lichtenberg previously taught at Harvard University and the University of Pennsylvania.  He has served as an expert for the Federal Trade Commission, the U.S. Dept. of Justice, and state Attorneys General, and has testified before Congress.  He has worked for several U.S. government agencies, including the Department of Justice, the Congressional Budget Office, and the Census Bureau, and been a visiting scholar at the Wissenschaftszentrum Berlin, the University of Munich, and elsewhere.  

Some of Professor Lichtenberg’s research has examined how the introduction of new technology arising from research and development affects the productivity of companies, industries and nations. Recently he has performed studies of the impact of pharmaceutical innovation on longevity, the effect of computers on productivity in business and government organizations, and the consequences of takeovers and leveraged buyouts for efficiency and employment.  His articles have been published in numerous scholarly journals and in the popular press.  His book Corporate Takeovers and Productivity has been published by MIT Press.  He was awarded the 1998 Schumpeter Prize for his paper, Pharmaceutical Innovation as a Process of Creative Destruction, and a 2003 Milken Institute Award for Distinguished Economic Research for the paper, Pharmaceutical Knowledge-Capital Accumulation and Longevity.

He has been awarded research fellowships, grants, and contracts by the National Science Foundation, the National Institute of Standards and Technology, Merck and Co., the Fulbright Commission, the Brookings Institution, the Alfred P. Sloan Foundation, The German Marshall Fund, the American Enterprise Institute, and other organizations.  He has served as a consultant to private organizations and government agencies including the Securities Industry Association, Pfizer, Inc., the Community Preservation Corporation, the RAND Corporation, the New York City Water Board, Touche Ross and Co., The Walt Disney Company, McGraw-Hill, and the National Pharmaceutical Council. He is an Affiliate of the economics consulting firm LECG, LLC.


Gary Frazier
Assistant Director, Healthcare and Pharmaceutical Management Program, Columbia Business School

After graduating from Columbia Business School in 1984, Gary held a number of positions in the pharmaceuticals industry.  As a marketing research analyst at Merck, Gary was involved in a variety of internal consulting projects in the areas of pricing, cost-benefit analysis, marketing, and strategic planning. As a product manager at Abbott Laboratories,  Gary was deeply involved in formulating promotional and anti-generics strategies for the company's largest revenue drug product at the time.  As a strategic planner at Pfizer, Gary coordinated inter-disciplinary teams responsible for the completion of the pharmaceutical division’s five-year strategic plan.

On Wall Street, Gary was a managed healthcare analyst during the nineties.  At Deutsche Bank and Bear Stearns, Gary formulated single-stock and industrywide stock allocation recommendations in the healthcare services sectors.  He was frequently quoted in The Wall Street Journal and on CNN and CNBC on managed care and national healthcare reform issues.

After his career on Wall Street Gary led Oxford Health Plans’ Investor Relations and Public Relations departments as Senior Vice President of Corporate Communications and founded his own investor relations consulting firm--Frazier Consulting, LLC. 

Officers of the HCIA are first- and second-year MBA students pursuing careers in the healthcare industry.

President Brad Sitko BSitko09@gsb.columbia.edu
VP, Alumni Matt Schabacker MSchabacker09@gsb.columbia.edu
VP, Careers Sean Maloney
Jeremy Brown
VP, Communications Allison Redmond ARedmond09@gsb.columbia.edu
VP, Conference Kate Leiser
Lisa Aceto
VP, Finance Eva Lindgren ELindgren09@gsb.columbia.edu
VP, Corporate Relations Chad Donaubauer
Julie O'Such
VP, Events Lisa Gohil
VP, J-Term Brooke Raphael BRaphael09@gsb.columbia.edu

© 2008 Columbia Business School :: Healthcare Industry Association